Beta-Hemolytic Streptococcus Culture, Group A Only
UFHPL Epic order code: LAB236
Rheumatic fever remains a concern in the United States and serious complications including sepsis, soft tissue invasion, and toxic shock-like syndrome have been reported to be increasing in frequency;1 therefore, timely diagnosis and early institution of appropriate therapy remains important. Timely therapy may reduce the acute symptoms and overall duration of streptococcal pharyngitis. The sequelae of poststreptococcal glomerulonephritis and rheumatic fever are diminished by early therapy.
As group A streptococci are uniformly susceptible to penicillin, there is no indication for monitoring susceptibility to penicillin and the emergence of resistance. Susceptibility testing is not routinely performed.
Type: Material from the patient's posterior pharynx, tonsils or other inflamed area
- Both tonsillar pillars and the oropharynx should be swabbed. Do not allow the swab to touch the patient's tongue.
Sample Volume: One or two swabs
- Unlabeled specimen or name discrepancy between specimen and request label
- Inappropriate specimen transport device
- Leaking specimen
- Specimen received after prolonged delay (usually more than 72 hours)
- Expired transport
Monday - Friday